Flock, smart-money disclosures made readable

PTC Therapeutics Inc

PTCTNASDAQ · US

Sign in for alerts Sign in to add to portfolio

Holders

Ownership

Ownership data not yet available for this security.

Disclosure timeline

REDUCEDT+2
Schmertzler Michael
PTC Therapeutics Inc · NASDAQ
−2,447 sh · $155.1K
Filed 9 Oct 2026SEC Form 4view source
REDUCEDT+2
Schmertzler Michael
PTC Therapeutics Inc · NASDAQ
−53 sh · $3.4K
Filed 9 Oct 2026SEC Form 4view source
REDUCEDT+7
Boulding Mark Elliott
PTC Therapeutics Inc · NASDAQ
−1,638 sh · $104.9K
Filed 7 Oct 2026SEC Form 4view source
ACQUIREDT+7
Boulding Mark Elliott
PTC Therapeutics Inc · NASDAQ
+1,638 sh · $64.6K
Filed 7 Oct 2026SEC Form 4view source
REDUCEDT+7
Boulding Mark Elliott
PTC Therapeutics Inc · NASDAQ
−435 sh · $27.9K
Filed 7 Oct 2026SEC Form 4view source
ACQUIREDT+7
Boulding Mark Elliott
PTC Therapeutics Inc · NASDAQ
+435 sh · $17.1K
Filed 7 Oct 2026SEC Form 4view source
REDUCEDT+30
Schmertzler Michael
PTC Therapeutics Inc · NASDAQ
−9,624 sh · $652.8K
Filed 18 Sept 2026SEC Form 4view source
REDUCEDT+30
Schmertzler Michael
PTC Therapeutics Inc · NASDAQ
−2,994 sh · $199.3K
Filed 18 Sept 2026SEC Form 4view source
REDUCEDT+30
Schmertzler Michael
PTC Therapeutics Inc · NASDAQ
−376 sh · $25.7K
Filed 18 Sept 2026SEC Form 4view source
REDUCEDT+30
Schmertzler Michael
PTC Therapeutics Inc · NASDAQ
−7,006 sh · $471.9K
Filed 18 Sept 2026SEC Form 4view source

Announcements

No announcements on record for this security.

Show all 29 disclosures

REDUCEDStale
Schmertzler Michael
PTC Therapeutics Inc · NASDAQ
−9,428 sh · $639.1K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Schmertzler Michael
PTC Therapeutics Inc · NASDAQ
−572 sh · $39.3K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Schmertzler Michael
PTC Therapeutics Inc · NASDAQ
−10,000 sh · $673.4K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Schmertzler Michael
PTC Therapeutics Inc · NASDAQ
−11,890 sh · $850.7K
Filed 28 Aug 2026SEC Form 4view source
REDUCEDStale
Schmertzler Michael
PTC Therapeutics Inc · NASDAQ
−6,874 sh · $500.0K
Filed 28 Aug 2026SEC Form 4view source
REDUCEDStale
Schmertzler Michael
PTC Therapeutics Inc · NASDAQ
−610 sh · $44.1K
Filed 28 Aug 2026SEC Form 4view source
REDUCEDStale
Schmertzler Michael
PTC Therapeutics Inc · NASDAQ
−5,626 sh · $411.7K
Filed 28 Aug 2026SEC Form 4view source
REDUCEDStale
Schmertzler Michael
PTC Therapeutics Inc · NASDAQ
−691 sh · $50.4K
Filed 21 Aug 2026SEC Form 4view source
REDUCEDStale
Schmertzler Michael
PTC Therapeutics Inc · NASDAQ
−2,390 sh · $171.8K
Filed 21 Aug 2026SEC Form 4view source
REDUCEDStale
Schmertzler Michael
PTC Therapeutics Inc · NASDAQ
−5,335 sh · $388.7K
Filed 21 Aug 2026SEC Form 4view source
REDUCEDStale
Schmertzler Michael
PTC Therapeutics Inc · NASDAQ
−7,165 sh · $527.8K
Filed 21 Aug 2026SEC Form 4view source
REDUCEDStale
Schmertzler Michael
PTC Therapeutics Inc · NASDAQ
−9,419 sh · $666.7K
Filed 21 Aug 2026SEC Form 4view source
REDUCEDStale
Boulding Mark Elliott
PTC Therapeutics Inc · NASDAQ
−969 sh · $70.6K
Filed 19 Aug 2026SEC Form 4view source
ACQUIREDStale
Boulding Mark Elliott
PTC Therapeutics Inc · NASDAQ
+2,813 sh · $72.3K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDStale
Boulding Mark Elliott
PTC Therapeutics Inc · NASDAQ
−1,844 sh · $133.5K
Filed 19 Aug 2026SEC Form 4view source
DISCLOSEDQuarterly
Polen Capital Management
PTC Therapeutics Inc · NASDAQ
24,916 sh · $2.0M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDStale
Two Sigma Investments
PTC Therapeutics Inc · NASDAQ
27,110 sh · $1.8M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Renaissance Technologies
PTC Therapeutics Inc · NASDAQ
533,300 sh · $36.3M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
BlackRock
PTC Therapeutics Inc · NASDAQ
7,772,140 sh · $237.7M
Filed 30 Jun 2024SEC 13Fview source